These results are consistent with our previous findings using panobinostat [14], suggesting that HDAC1, HDAC2, and HDAC3 participate in the regulation of BRCA1, CHK1, and RAD51 expression and play important roles in the antileukemic activities of ara-C or DNR in AML cells. The gene discussed is BRCA1; the disease is acute myeloid leukemia.